Skip to main content
TipRanks
Go Ultimate75% OFF

Howard Oconnell Insider Profile

4 Followers

Howard Oconnell, Director at Bio-Techne, holds 77.00K shares in Bio-Techne (Ticker: TECH). Most recently, Howard Oconnell Sold 5,000 shares of Bio-Techne on Feb 20, 2015 for an estimated value of $478.85K.

Howard Oconnell's Trading History

TECH
Bio-Techne
Feb 20, 2015DirectorInformative Sell478.85K$5.61M
TECH
Insider Shares: 77.00K (0.21%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Feb 20, 2015Informative Sell$478.85K5,000$95.77+6.90%
Nov 03, 2014Uninformative Buy$0.001,000$0.00―
May 08, 2014Informative Sell$455.00K5,000$91.00-10.30%
Nov 04, 2013Uninformative Buy$0.001,000$0.00―
May 07, 2013Informative Buy$153.47K2,361$65.00―

You May Also Like

Howard Oconnell insider profile FAQ

What is the percentage of profitable transactions made by Howard Oconnell?
The percentage of profitable transactions made by Howard Oconnell is 50%.
What is the average return per transaction made by Howard Oconnell?
The average return per transaction made by Howard Oconnell is -1.70%.
What stocks does Howard Oconnell hold?
Howard Oconnell holds: TECH stocks.
What was Howard Oconnell’s latest transaction?
Howard Oconnell’s latest transaction was an Informative Sell of $478.85K.
What was Howard Oconnell's most profitable transaction?
Howard Oconnell’s most profitable transaction was an Informative Sell of TECH stock on February 20, 2015. The return on the trade was 6.90%.
What is Howard Oconnell's role in Bio-Techne?
Howard Oconnell's role in Bio-Techne is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.